Herpetic whitlow
Methodology & AI Transparency ⓘ
Herpetic whitlow Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Herpetic whitlow—coded clinically as B00.89 across Infections & Antivirals guidelines—combines sepsis/severity red-flag triage [Herpetic whitlow B00.89] with structured follow-up of Targeted PCR / in Herpetic whitlow (B00.89: Culture & Sensitivity) (Pathogen clearance / negative test (B00.89)).
- 2 Real-world patient consensus: Clinical coding for Herpetic whitlow uses ICD-10 B00.89 across Infections & Antivirals specialty care.
- 3 Typical cash cost range: Clinicians assessing Herpetic whitlow focus on or latent viral in Herpetic whitlow (B00.89: reactivation within sensory) and targeted history.
- 4 Top reported side effects / signs: Objective lab/clinical target for Herpetic whitlow: C-Reactive Protein / in Herpetic whitlow (B00.89: Procalcitonin) (Resolution to baseline (B00.89)) and Targeted PCR / in Herpetic whitlow (B00.89: Culture & Sensitivity).
Ask our AI Specialists anything about Herpetic whitlow
What Is Herpetic whitlow?
Herpetic whitlow—coded clinically as B00.89 across Infections & Antivirals guidelines—combines sepsis/severity red-flag triage [Herpetic whitlow B00.89] with structured follow-up of Targeted PCR / in Herpetic whitlow (B00.89: Culture & Sensitivity) (Pathogen clearance / negative test (B00.89)).
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Herpetic whitlow (ICD-10 B00.89) is driven by or latent viral in Herpetic whitlow (B00.89: reactivation within sensory); specialists in Bacterial, Viral & Fungal Infections monitor Targeted PCR / in Herpetic whitlow (B00.89: Culture & Sensitivity) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Herpetic whitlow (B00.89): regional lymph node in Herpetic whitlow (B00.89: tenderness or acute)
- • Secondary Herpetic whitlow clinical sign: acute fever, chills, in Herpetic whitlow (B00.89: malaise, and myalgias)
- • Symptom flares in Herpetic whitlow correlating with C-Reactive Protein / in Herpetic whitlow (B00.89: Procalcitonin) deviation outside Resolution to baseline (B00.89)
- • Functional infections & antivirals impact requiring sepsis/severity red-flag triage [Herpetic whitlow B00.89] evaluation (B00.89)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Herpetic whitlow Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | B00.89 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Bacterial, Viral & Fungal Infections | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: C-Reactive Protein / in Herpetic whitlow (B00.89: Procalcitonin) | Resolution to baseline (B00.89) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Targeted PCR / in Herpetic whitlow (B00.89: Culture & Sensitivity) | Pathogen clearance / negative test (B00.89) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Complete Blood Count in Herpetic whitlow (B00.89: (WBC & Differential)) | WBC 4.0 – 10.0 x10^3/uL (B00.89) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Herpetic whitlow
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Lidocaine 5% Healthwise Anorectal Pain Relief, Lubricaine 5 • RxCUI 1745091 | Amide Local Anesthetic | 90% | $0.0989 | $ 12.50 /mo |
| Ganciclovir Zirgan • RxCUI 388052 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor | 85% | $91.2378 | $ 185.00 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Herpetic whitlow)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides This analysis provides further evidence of RBL real-world benefits and safety across subgroups, including those at high risk for rCDI. Journal of clinical gastroenterology • 2024-09-01 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 38019088 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of twice-daily tramadol hydrochloride bilayer Sustained-release tramadol tablets with an immediate-release component are effective and well tolerated for managing postherpetic neuralgia. Pain practice : the official journal of World Institute of Pain • 2023-03-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 36478501 ↗ |
| Can This Approach Help? Inside the Latest Research on Oral gepotidacin for the treatment of uncomplicated urinary tract infection in Gepotidacin therapeutic success at test-of-cure was consistent between EAGLE-J and EAGLE-2/-3. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy • 2026-01-15 • Phase III Randomized Trial | N = 108 | 88/100 | PMID 41109603 ↗ |
Herpetic whitlow Patient Community & “People Like Me” Threads
Filter Herpetic whitlow community threads and patient logs by age, biological sex, dosage, and treatment duration.